Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development - Pharmafile
Summary by pharmafile.com
1 Articles
1 Articles
All
Left
Center
Right
Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development - Pharmafile
Oxford-based biotechnology company Ochre Bio has announced the appointment of Quin Wills as CEO. As co-founder of the company and previously its chief scientific officer, Wills has played a central role in shaping Ochre’s approach to developing RNA-based therapies for chronic liver disease. The appointment signals a new phase of growth for Ochre as it […] The post Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics deve…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium